REVIUM Rx.
RVRCCIK 0001839140
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$13.45M
−545.3% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.22
−450.0% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$920K
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
60.73M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Revenue Growth (YoY)
No data available for this metric.